{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:51:43Z","timestamp":1788274303594,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["CA23-0020"],"award-info":[{"award-number":["CA23-0020"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["CA23-0020"],"award-info":[{"award-number":["CA23-0020"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["CA23-0020"],"award-info":[{"award-number":["CA23-0020"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["CA23-0020"],"award-info":[{"award-number":["CA23-0020"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gender influences health outcomes by affecting exposure to risk factors, healthcare access, and health-seeking behaviours. Yet, many studies fail to consider how these gendered experiences interact with other social factors, such as age, socioeconomic status, and ethnicity. Our study systematically mapped existing research to identify gaps in understanding how these factors affect service delivery outcomes related to antimicrobial resistance (AMR) for infectious diseases of poverty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review and evidence gap map analysis following PRISMA 2020 guidelines. A comprehensive search was conducted across five major databases (MEDLINE, EMBASE, Scopus, Cochrane Library, and Web of Science) for studies published up to March 31, 2024. To synthesise the evidence, we developed and applied a specialized \u2018Guide for an Intersectionality Approach\u2019, adapted from established frameworks, to evaluate how gender identity, gender roles, and norms intersect with social factors like age, socioeconomic status, and ethnicity to influence AMR service delivery outcomes in Low- and Lower-Middle-Income Countries (LLMICs) for malaria, tuberculosis (TB) and neglected tropical diseases (NTDs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 38,310 identified records, 14 studies met the inclusion criteria, all of which focused exclusively on TB; no eligible evidence was found for other infectious diseases of poverty like malaria or NTDs. While all included studies provided sex-disaggregated data, there was a significant lack of deeper intersectional analysis, with zero studies exploring non-traditional gender roles, power dynamics, or the compounded effects of intersecting social stratifiers. Findings indicated sex parity in diagnostic access but revealed male-specific vulnerabilities in treatment retention and a 4.06-fold higher risk of mortality for men. Conversely, women faced higher risks of treatment delays in certain contexts and often relied on informal antibiotic sources.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There is a lack of studies evaluating how social determinants shaped by gender dynamics (roles, norms, relations, and power) influences inequities and vulnerabilities caused by AMR in LMICs. This gap limits our understanding of how these intersections affect antibiotic use, healthcare access, and treatment adherence. Future research should use intersectionality as an analytical framework and mixed-methods approaches to develop more inclusive and equitable health interventions that address the compounded inequities and vulnerabilities associated with gender and other social factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-026-26990-5","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:18:04Z","timestamp":1773667084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gender and other intersecting factors in antimicrobial resistance for infectious diseases of poverty: a systematic evidence gap analysis in low- and lower-middle-income countries"],"prefix":"10.1186","volume":"26","author":[{"given":"Dhanajayan","family":"Govindan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuvaraj","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Gilbert","family":"Majella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Karunakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"26990_CR1","first-page":"30212103","volume-title":"Major Infectious Diseases","author":"C Fitzpatrick","year":"2017","unstructured":"Fitzpatrick C, Nwankwo U, Lenk E, de Vlas SJ, Bundy DAP. An Investment Case for Ending Neglected Tropical Diseases. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd ed. Washington (DC): The International Bank for Reconstruction and Development \/ The World Bank; 2017. p. 30212103. Nov 3. Chapter 17. PMID.","edition":"3"},{"key":"26990_CR2","unstructured":"World Health Organization. Neglected tropical diseases . Geneva: World Health Organization. 2024 [Cited 2024 Jul 17]. Available from: https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/neglected-tropical-diseases"},{"key":"26990_CR3","doi-asserted-by":"publisher","unstructured":"De Rijk S, Klemperer K, Depierreux D, Fu Z, Mackinlay K, Terry R. Protecting the neglected from disease: the role of gender, health equity and human rights in the fight against neglected tropical diseases. [Preprint]. 2021 Mar 4. Available from: https:\/\/doi.org\/10.31235\/osf.io\/m7kpu","DOI":"10.31235\/osf.io\/m7kpu"},{"key":"26990_CR4","unstructured":"World Health Organization. Antimicrobial resistance. Geneva: World health Organization; 2023 [Cited 2024 Jul 17]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance"},{"issue":"13","key":"26990_CR5","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.3390\/healthcare11131946","volume":"11","author":"MA Salam","year":"2023","unstructured":"Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA, Alqumber MA, et al. Antimicrobial resistance: a growing serious threat for global public health. Healthc (Basel). 2023;11(13):1946. https:\/\/doi.org\/10.3390\/healthcare11131946.","journal-title":"Healthc (Basel)"},{"key":"26990_CR6","doi-asserted-by":"crossref","unstructured":"Hamdani SS, Bhat BA, Tariq L, Yaseen SI, Ara I, Rafi B et al. Antibiotic resistance: the future disaster. Int J Res Appl Sci Biotechnol. 2020;7.","DOI":"10.31033\/ijrasb.7.4.16"},{"issue":"3","key":"26990_CR7","doi-asserted-by":"publisher","first-page":"dlad062","DOI":"10.1093\/jacamr\/dlad062","volume":"5","author":"II Otaigbe","year":"2023","unstructured":"Otaigbe II, Elikwu CJ. Drivers of inappropriate antibiotic use in low-and middle-income countries. JAC-Antimicrob Resist. 2023;5(3):dlad062.","journal-title":"JAC-Antimicrob Resist"},{"key":"26990_CR8","doi-asserted-by":"crossref","unstructured":"Desai K, Arora P. Burden of infectious diseases and strategies of prevention. In: Viral, Parasitic, Bacterial, and Fungal Infections. 2023. pp. 49\u201361.","DOI":"10.1016\/B978-0-323-85730-7.00052-7"},{"issue":"9","key":"26990_CR9","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/heapol\/czad054","volume":"38","author":"JM Gautron","year":"2023","unstructured":"Gautron JM, Tu Thanh G, Barasa V, Voltolina G. Using intersectionality to study gender and antimicrobial resistance in low-and middle-income countries. Health Policy Plan. 2023;38(9):1017\u201332.","journal-title":"Health Policy Plan"},{"issue":"2","key":"26990_CR10","first-page":"309","volume":"74","author":"J Swinkels","year":"2019","unstructured":"Swinkels J, Tilburg TV, Verbakel E, Broese van Groenou M. Explaining the gender gap in the caregiving burden of partner caregivers. J Gerontol B Psychol Sci Soc Sci. 2019;74(2):309\u201317.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"26990_CR11","unstructured":"Womankind Worldwide. Intersectionality 101: what is it and why is it important? . 2019 [Cited 2024 Jul 17]. Available from: https:\/\/www.womankind.org.uk\/intersectionality-101-what-is-it-and-why-is-it-important\/"},{"key":"26990_CR12","doi-asserted-by":"publisher","first-page":"e1994","DOI":"10.18294\/sc.2019.1994","volume":"15","author":"MT Couto","year":"2019","unstructured":"Couto MT, Oliveira ED, Separavich MA, Luiz OD. The feminist perspective of intersectionality in the field of public health: a narrative review of the theoretical-methodological literature. Salud Colectiva. 2019;15:e1994.","journal-title":"Salud Colectiva"},{"key":"26990_CR13","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372.","DOI":"10.1136\/bmj.n71"},{"key":"26990_CR14","unstructured":"World Health Organization. Neglected tropical diseases . 2024 [Cited 2024 Jul 17]. Available from: https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/neglected-tropical-diseases"},{"key":"26990_CR15","unstructured":"World Bank. World Bank country and lending groups. World Bank Data Help Desk. 2024. Available from: https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups"},{"key":"26990_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s13280-016-0825-2","volume":"45","author":"H Djoudi","year":"2016","unstructured":"Djoudi H, Locatelli B, Vaast C, Asher K, Brockhaus M, Basnett Sijapati B. Beyond dichotomies: Gender and intersecting inequalities in climate change studies. Ambio. 2016;45:248\u201362.","journal-title":"Ambio"},{"key":"26990_CR17","unstructured":"Understanding. gender, sex and intersectionality and why it matters for infectious diseases of poverty . 2020 [Cited 2024 Sep 9]. Available from: https:\/\/tdr-intersectional-gender-toolkit.org\/module-1\/0001.html?target=_self&lightbox=0"},{"key":"26990_CR18","unstructured":"Understanding Power Dynamics and Privilege . 2023 [Cited 2024 Sep 9]. Available from: https:\/\/amchp.org\/resources\/understanding-power-dynamics-and-privilege\/"},{"key":"26990_CR19","unstructured":"Schlosser M. Agency. In: Zalta EN, editor. The Stanford Encyclopedia of Philosophy . 2019 [Cited 2024 Sep 9]. Available from: https:\/\/plato.stanford.edu\/archives\/spr2019\/entries\/agency\/"},{"key":"26990_CR20","first-page":"1024","volume-title":"The Encyclopedia of Political Thought","author":"S Susen","year":"2015","unstructured":"Susen S. Emancipation. In: Gibbons MT, Coole D, Ellis E, Ferguson K, editors. The Encyclopedia of Political Thought. Chichester (UK): Wiley Blackwell; 2015. pp. 1024\u201338."},{"issue":"4","key":"26990_CR21","doi-asserted-by":"publisher","first-page":"e0215542","DOI":"10.1371\/journal.pone.0215542","volume":"14","author":"C Oga-Omenka","year":"2019","unstructured":"Oga-Omenka C, Zarowsky C, Agbaje A, Kuye J, Menzies D. Rates and timeliness of treatment initiation among drug-resistant tuberculosis patients in Nigeria- A retrospective cohort study. PLoS ONE. 2019;14(4):e0215542.","journal-title":"PLoS ONE"},{"key":"26990_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ijid.2019.02.007","volume":"81","author":"C Timire","year":"2019","unstructured":"Timire C, Sandy C, Kumar AMV, Ngwenya M, Murwira B, Takarinda KC, Harries AD. Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain\u00ae Line Probe Assay in Southern provinces, Zimbabwe. Int J Infect Dis. 2019;81:236\u201343.","journal-title":"Int J Infect Dis"},{"issue":"S1","key":"26990_CR23","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.ijtb.2024.01.001","volume":"71","author":"L Kumar","year":"2024","unstructured":"Kumar L, Kumar S, Vohra V, Mohan K, Khayyam KU. Risk factors of treatment interruptions among drug-sensitive and drug-resistant pulmonary tuberculosis patients-A study from South Delhi, New Delhi, India. Indian J Tuberc. 2024;71(S1):S72\u20136.","journal-title":"Indian J Tuberc"},{"issue":"Suppl 1","key":"26990_CR24","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.5588\/pha.18.0075","volume":"9","author":"E Hapolo","year":"2019","unstructured":"Hapolo E, Ilai J, Francis T, Du Cros P, Taune M, Chan G. TB treatment delay associated with drug resistance and admission at Daru General Hospital in Papua New Guinea. Public Health Action. 2019;9(Suppl 1):S50.","journal-title":"Public Health Action"},{"issue":"12","key":"26990_CR25","doi-asserted-by":"publisher","first-page":"e0209932","DOI":"10.1371\/journal.pone.0209932","volume":"13","author":"YM Htun","year":"2018","unstructured":"Htun YM, Khaing TM, Aung NM, Yin Y, Myint Z, Aung ST, et al. Delay in treatment initiation and treatment outcomes among adult patients with multidrug-resistant tuberculosis at Yangon Regional Tuberculosis Centre, Myanmar: a retrospective study. PLoS ONE. 2018;13(12):e0209932.","journal-title":"PLoS ONE"},{"key":"26990_CR26","doi-asserted-by":"publisher","first-page":"100153","DOI":"10.1016\/j.jctube.2020.100153","volume":"19","author":"J Izudi","year":"2020","unstructured":"Izudi J, Tamwesigire IK, Bajunirwe F. Surveillance for multi-drug and rifampicin resistant tuberculosis and treatment outcomes among previously treated persons with tuberculosis in the era of GeneXpert in rural eastern Uganda. J Clin Tuberc Other Mycobact Dis. 2020;19:100153.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"26990_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijid.2022.09.012","volume":"124","author":"CG Jouego","year":"2022","unstructured":"Jouego CG, Gils T, Piubello A, Mbassa V, Kuate A, Ngono A, et al. Programmatic management of rifampicin-resistant tuberculosis with standard regimen in Cameroon: a retrospective cohort study. Int J Infect Dis. 2022;124:81\u20138.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"26990_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jegh.2017.07.001","volume":"7","author":"HD Shewade","year":"2017","unstructured":"Shewade HD, Nair D, Klinton JS, Parmar M, Patel N, Kuriya S, et al. Low pre-diagnosis attrition but high pre-treatment attrition among patients with MDR-TB: An operational research from Chennai, India. J Epidemiol Glob Health. 2017;7(4):227\u201333.","journal-title":"J Epidemiol Glob Health"},{"issue":"11","key":"26990_CR29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/trstmh\/try091","volume":"112","author":"HD Shewade","year":"2018","unstructured":"Shewade HD, Shringarpure KS, Parmar M, Patel N, Kuriya S, Shihora S, et al. Delay before drug susceptibility testing among patients with presumptive multidrug-resistant tuberculosis in Gujarat, India. Trans R Soc Trop Med Hyg. 2018;112(11):500\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"26","key":"26990_CR30","doi-asserted-by":"publisher","first-page":"34953","DOI":"10.1007\/s11356-021-13196-y","volume":"28","author":"A Arif","year":"2021","unstructured":"Arif A, Ahmad E, Khan FN, Fatima R. A cohort study analyzing the impact of socioeconomic and spatial characteristics alongside treatment regimens on the environmental-health outcomes of the MDR-TB treatment in Pakistan. Environ Sci Pollut Res Int. 2021;28(26):34953\u201367.","journal-title":"Environ Sci Pollut Res Int"},{"issue":"8","key":"26990_CR31","first-page":"407","volume":"8","author":"B Kyrbashov","year":"2023","unstructured":"Kyrbashov B, Kulzhabaeva A, Kadyrov A, Toktogonova A, Timire C, Satyanarayana S, et al. Time to treatment and risk factors for unsuccessful treatment outcomes among people who started second-line treatment for rifampicin-resistant or multi-drug-resistant tuberculosis in the Kyrgyz Republic, 2021. Trop Med Infect Dis. 2023;8(8):407.","journal-title":"Trop Med Infect Dis"},{"issue":"2","key":"26990_CR32","doi-asserted-by":"publisher","first-page":"e0116721","DOI":"10.1371\/journal.pone.0116721","volume":"10","author":"N Raizada","year":"2015","unstructured":"Raizada N, Sachdeva KS, Sreenivas A, Kulsange S, Gupta RS, Thakur R, et al. Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB\/RIF testing for people living with HIV in India. PLoS ONE. 2015;10(2):e0116721.","journal-title":"PLoS ONE"},{"issue":"2","key":"26990_CR33","doi-asserted-by":"publisher","first-page":"e0193194","DOI":"10.1371\/journal.pone.0193194","volume":"13","author":"N Raizada","year":"2018","unstructured":"Raizada N, Khaparde SD, Salhotra VS, Rao R, Kalra A, Swaminathan S, et al. Accelerating access to quality TB care for pediatric TB cases through better diagnostic strategy in four major cities of India. PLoS ONE. 2018;13(2):e0193194.","journal-title":"PLoS ONE"},{"key":"26990_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-018-3077-y","volume":"18","author":"SD Sidharta","year":"2018","unstructured":"Sidharta SD, Yin JD, Yoong JS, Khan MS. High use of private providers for first healthcare seeking by drug-resistant tuberculosis patients: a cross-sectional study in Yangon, Myanmar. BMC Health Serv Res. 2018;18:1\u20137.","journal-title":"BMC Health Serv Res"},{"key":"26990_CR35","doi-asserted-by":"publisher","unstructured":"Mahendran M, Lizotte D, Bauer GR. Quantitative methods for descriptive intersectional analysis with binary health outcomes. SSM Popul Health. 2022;17:101032. https:\/\/doi.org\/10.1016\/j.ssmph.2022.101032. PMID: 35118188; PMCID: PMC8800141.","DOI":"10.1016\/j.ssmph.2022.101032"},{"issue":"9","key":"26990_CR36","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/heapol\/czad054","volume":"38","author":"JMC Gautron","year":"2023","unstructured":"Gautron JMC, Tu Thanh G, Barasa V, Voltolina G. Using intersectionality to study gender and antimicrobial resistance in low- and middle-income countries. Health Policy Plan. 2023;38(9):1017\u201332. https:\/\/doi.org\/10.1093\/heapol\/czad054.","journal-title":"Health Policy Plan"},{"key":"26990_CR37","doi-asserted-by":"publisher","first-page":"1429203","DOI":"10.3389\/fgwh.2024.1429203","volume":"5","author":"V Barasa","year":"2024","unstructured":"Barasa V. A one health approach to tackling AMR and why gender matters: findings from pastoralist communities in Tanzania. Front Glob Womens Health. 2024;5:1429203. https:\/\/doi.org\/10.3389\/fgwh.2024.1429203.","journal-title":"Front Glob Womens Health"},{"key":"26990_CR38","doi-asserted-by":"publisher","unstructured":"Blackmon S, Avendano E, Nirmala N, Chan CW, Morin RA, Balaji S et al. Socioeconomic status and the risk for colonization or infection with priority bacterial pathogens: a global evidence map. medRxiv [Preprint]. 2024 Apr 24. https:\/\/doi.org\/10.1101\/2024.04.24.24306293","DOI":"10.1101\/2024.04.24.24306293"},{"issue":"1","key":"26990_CR39","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1186\/s12889-021-10972-w","volume":"21","author":"HM Garrison-Desany","year":"2021","unstructured":"Garrison-Desany HM, Wilson E, Munos M, Sawadogo-Lewis T, Ma\u00efga A, Ako O, et al. The role of gender power relations on women\u2019s health outcomes: evidence from a maternal health coverage survey in Simiyu region, Tanzania. BMC Public Health. 2021;21(1):909. https:\/\/doi.org\/10.1186\/s12889-021-10972-w.","journal-title":"BMC Public Health"},{"key":"26990_CR40","unstructured":"United Nations Framework Convention on Climate Change. Gender Equality Spectrum . [Cited 2024 Nov 10]. Available from: https:\/\/unfccc.int\/sites\/default\/files\/resource\/Session6_230321_GESI_intro_and_overview.pdf"},{"issue":"14","key":"26990_CR41","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.3390\/ijerph20146370","volume":"20","author":"L Tinner","year":"2023","unstructured":"Tinner L, Holman D, Ejegi-Memeh S, Laverty AA. Use of Intersectionality Theory in Interventional Health Research in High-Income Countries: A Scoping Review. Int J Environ Res Public Health. 2023;20(14):6370. https:\/\/doi.org\/10.3390\/ijerph20146370.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"26990_CR42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12939-024-02109-3","volume":"23","author":"MR Arrivillaga","year":"2024","unstructured":"Arrivillaga MR, Gold M, Rivera EP, Ju\u00e1rez JG. Incorporating an intersectional gender approach to improve access to maternal and child health screening services. Int J Equity Health. 2024;23(1):32. https:\/\/doi.org\/10.1186\/s12939-024-02109-3.","journal-title":"Int J Equity Health"},{"issue":"2","key":"26990_CR43","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/1467-9566.13008","volume":"42","author":"B Cislaghi","year":"2020","unstructured":"Cislaghi B, Heise L. Gender norms and social norms: differences, similarities and why they matter in prevention science. Sociol Health Illn. 2020;42(2):407\u201322. https:\/\/doi.org\/10.1111\/1467-9566.13008.","journal-title":"Sociol Health Illn"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-26990-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26990-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26990-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:11:41Z","timestamp":1781640701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-26990-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["26990"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-26990-5","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"None declared.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of artificial intelligence tools"}}],"article-number":"1322"}}